A detailed history of Norden Group LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Norden Group LLC holds 658,856 shares of NVO stock, worth $89.1 Million. This represents 0.94% of its overall portfolio holdings.

Number of Shares
658,856
Previous 25,777 2455.98%
Holding current value
$89.1 Million
Previous $2.67 Billion 3072.44%
% of portfolio
0.94%
Previous 0.46%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 30, 2024

SELL
$102.11 - $135.92 $64.2 Million - $85.5 Million
-628,951 Reduced 95.46%
29,905 $3.84 Billion
Q1 2024

Apr 19, 2024

BUY
$102.11 - $135.92 $64.6 Million - $86 Million
633,079 Added 2455.98%
658,856 $84.6 Billion
Q4 2023

Feb 05, 2024

SELL
$87.78 - $105.45 $323,118 - $388,161
-3,681 Reduced 12.5%
25,777 $2.67 Billion
Q3 2023

Nov 06, 2023

BUY
$90.94 - $199.54 $2.68 Million - $5.88 Million
29,458 New
29,458 $2.68 Billion

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $305B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Norden Group LLC Portfolio

Follow Norden Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Norden Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Norden Group LLC with notifications on news.